Third Harmonic Bio Inc. (THRD NASDAQ) stock market data APIs
$5.3576
0(0%)
as of August 13, 2025
Try our APIs with
free plan!
Third Harmonic Bio Inc. Financial Data Overview
Price chart is built with
Anychart
Third Harmonic Bio, Inc., a biopharmaceutical company, focuses on the development of the medicine for the treatment of dermal, respiratory, and gastrointestinal inflammatory diseases. The company develops oral small-molecule inhibitors of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. It also develops THB335, an oral small molecule KIT inhibitor for the treatment of mast cell-mediated inflammatory diseases, respiratory, and gastrointestinal conditions. It has a license agreement with Novartis Pharma AG. The company was formerly known as Project IGE, Inc. and changed its name to Third Harmonic Bio, Inc. in June 2019. Third Harmonic Bio, Inc. was incorporated in 2019 and is headquartered in San Francisco, California.
Prev. Close
5.3576
Open
5.3576
High
5.3576
Low
5.3576
52 wk Range
3.3-5.525
Market Cap
243 M
Shares Outstanding
45 128 K
EPS
0
Beta
2.132
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Third Harmonic Bio Inc. (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Third Harmonic Bio Inc. data using free add-ons & libraries
Get Third Harmonic Bio Inc. Fundamental Data
Third Harmonic Bio Inc. Fundamental data includes:
- Net Revenue:
- EBITDA: -64 248 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-06
- EPS/Forecast: -0.18
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Third Harmonic Bio Inc. News
New
Hercules Technology Growth Capital Breaks Below 200-Day Moving Average - Notable for HTGC
In trading on Monday, shares of Hercules Technology Growth Capital (Symbol: HTGC) crossed below their 200 day moving average of $19.14, changing hands as low as $19.05 per share. Hercules Technology ...
AstraZeneca forms an AI deal in China; Third Harmonic advances liquidation plans
This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. Today, a brief rundown of news involving AstraZeneca ...
Here’s Why Third Harmonic Bio (THRD) Fell in Q1
1 Main Capital, a boutique investment firm, released its first-quarter 2025 investor letter. A copy of the letter can be downloaded here. The fund returned (3.6)% net in the first quarter compared to...
Third Harmonic Bio Announces Plan of Liquidation and Dissolution
Board of Directors has approved plan to liquidate and intends to seek stockholder approval for dissolution of the Company at the Annual Meeting of Stockholders on June 5, 2025 Initial distribution ex...
Get Third Harmonic Bio Inc. fresh news feed via Financial News API
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
